Vincenzo Bagnardi

7PUBLICATIONS
57CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersDeep learningEpidemiological methodsPacific Peoples life course
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 15, 2026
Extended Endocrine Therapy Following 5 Years of Adjuvant Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal Patients With Node-Positive, Hormone Receptor-Positive Breast Cancer: A Cohort Study.

Carmine Valenza, Yue Zheng, Monica Milano

|Sep 17, 2025
Why Adjuvant Treatment With a CDK4/6 Inhibitor Should Be Recommended for Women With High-Risk Breast Cancer: Methodologic Considerations on Available Evidence.

Fabio Conforti, Federico Merlo, Laura Pala

|Jul 02, 2025
Reply to: "Inappropriate Conclusions on Surrogate End Points in Early Breast Cancer Trials" and "Methodologic Considerations in Assessing Invasive Disease-Free Survival as a Surrogate End Point for Overall Survival in Trials for Early Breast Cancer".

Fabio Conforti, Vincenzo Bagnardi, Isabella Sala

|Jan 30, 2025
Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast Cancer.

Fabio Conforti, Valentina Nekljudova, Isabella Sala

|Aug 13, 2024
Development and Validation of a Natural Language Processing Algorithm for Extracting Clinical and Pathological Features of Breast Cancer From Pathology Reports.

Elisabetta Munzone, Antonio Marra, Federico Comotto

|Jan 17, 2024
Dose-response association between cigarette smoking and gastric cancer risk: a systematic review and meta-analysis.

Matteo Rota, Irene Possenti, Valeria Valsassina

Pageof 2

Frequent Collaborators

4 joint publications

Fabio Conforti

2 joint publications

Laura Pala

2 joint publications

Tommaso De Pas

2 joint publications

Richard Gelber